Analystreport

Seres Therapeutics Inc (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald.

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com